Table of Contents Author Guidelines Submit a Manuscript
Journal of Sensors
Volume 2017, Article ID 6792396, 9 pages
https://doi.org/10.1155/2017/6792396
Research Article

Peptide Functionalization of Silicon for Detection and Classification of Prostatic Cells

1Institute for Microelectronics and Microsystems, Unit of Naples, National Research Council, Naples, Italy
2Department of Biochemistry, Biophysics and General Pathology, University of Campania “L. Vanvitelli”, Naples, Italy
3Department of Pharmacy, University of Naples “Federico II”, Naples, Italy

Correspondence should be addressed to Luca De Stefano; ti.rnc.mmi.an@onafetsed.acul

Received 9 February 2017; Accepted 24 July 2017; Published 30 August 2017

Academic Editor: Mike McShane

Copyright © 2017 Jane Politi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Loeb and W. J. Catalona, “What to do with an abnormal PSA test,” Oncologist, vol. 13, no. 3, pp. 299–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Cristofanilli, G. T. Budd, M. J. Ellis et al., “Circulating tumor cells, disease progression, and survival in metastatic breast cancer,” The New England Journal of Medicine, vol. 351, no. 8, pp. 781–791, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Feldstein and M. Zelen, “Inferring the natural time history of breast cancer: Implications for tumor growth rate and early detection,” Breast Cancer Research and Treatment, vol. 4, no. 1, pp. 3–10, 1984. View at Publisher · View at Google Scholar · View at Scopus
  4. C. J. Logothetis, N. M. Navone, and S.-H. Lin, “Understanding the biology of bone metastases: Key to the effective treatment of prostate cancer,” Clinical Cancer Research, vol. 14, no. 6, pp. 1599–1602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. I. G. McIntyre, K. Spreckley, and R. B. Clarke, “Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells,” British Journal of Cancer, vol. 83, pp. 992–997, 2000. View at Google Scholar
  6. S. Tai, Y. Sun, J. M. Squires et al., “PC3 is a cell line characteristic of prostatic small cell carcinoma,” Prostate, vol. 71, no. 15, pp. 1668–1679, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. R. Dodds, V. J. Caride, and B. Lytton, “The role of vertebral veins in the dissemination of prostatic carcinoma,” The Journal of Urology, vol. 126, no. 6, pp. 753–755, 1981. View at Publisher · View at Google Scholar
  8. G. Sardana, K. Jung, C. Stephan, and E. P. Diamandis, “Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers,” Journal of Proteome Research, vol. 7, no. 8, pp. 3329–3338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. P. S. Steeg, “Tumor metastasis: mechanistic insights and clinical challenges,” Nature Medicine, vol. 12, no. 8, pp. 895–904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. T. Tan, J. Low, S. G. Lim, and M. C. M. Chung, “Serum autoantibodies as biomarkers for early cancer detection,” The FEBS Journal, vol. 276, no. 23, pp. 6880–6904, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Marra, G. Salzano, C. Leonetti et al., “Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 7, no. 6, pp. 955–964, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Caraglia, A. Budillon, P. Tagliaferri, M. Marra, A. Abbruzzese, and F. Caponigro, “Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: Preclinical and clinical implications,” Current Drug Targets, vol. 6, no. 3, pp. 301–323, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Caraglia, M. Marra, C. Leonetti et al., “R115777 (Zarnestra®)/zoledronic acid (Zometa®) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation,” Journal of Cellular Physiology, vol. 211, no. 2, pp. 533–543, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Moll, W. W. Franke, D. L. Schiller, B. Geiger, and R. Krepler, “The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells,” Cell, vol. 31, no. 1, pp. 11–24, 1982. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Grieco, R. Franco, G. Bozzuto et al., “Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells,” Journal of Cellular Biochemistry, vol. 112, no. 1, pp. 341–353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. S. Ligler and C. A. Rowe Taitt, Optical Biosensors, Elsevier, Amsterdam, Netherlands, 2004.
  17. A. F. Collings and F. Caruso, “Biosensors: recent advances,” Reports on Progress in Physics, vol. 60, no. 11, pp. 1397–1445, 1997. View at Publisher · View at Google Scholar
  18. S. U. Senveli and O. Tigli, “Biosensors in the small scale: methods and technology trends,” IET Nanobiotechnology, vol. 7, no. 1, pp. 7–21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Tweedie, R. Subramanian, P. Lemoine et al., “Fabrication of impedimetric sensors for label-free Point-of-Care immunoassay cardiac marker systems, with passive microfluidic delivery,” in Proceedings of the Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society, pp. 4610–4614, New York, NY, USA, August 2006. View at Publisher · View at Google Scholar
  20. M. Vestergaard, K. Kerman, and E. Tamiya, “An overview of label-free electrochemical protein sensors,” Sensors, vol. 7, no. 12, pp. 3442–3458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Grieco, A. Carotenuto, P. Campiglia et al., “A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge,” Journal of Medicinal Chemistry, vol. 45, no. 20, pp. 4391–4394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Lamberti, C. Sanges, N. Migliaccio et al., “Silicon-based technology for ligand-receptor molecular identification,” Journal of Atomic, Molecular, and Optical Physics, vol. 2012, Article ID 948390, 5 pages, 2012. View at Publisher · View at Google Scholar
  23. A. Lamberti, C. Sanges, L. Rotiroti et al., “The ligand-receptor interactions based on silicon technology,” Current Topics in Biotechnology, vol. 5, pp. 49–54, 2009. View at Google Scholar
  24. J. W. Goding, “Use of staphylococcal protein A as an immunological reagent,” Journal of Immunological Methods, vol. 20, no. C, pp. 241–253, 1978. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Mattson, E. Conklin, S. Desai, G. Nielander, M. D. Savage, and S. Morgensen, “A practical approach to crosslinking,” Molecular Biology Reports, vol. 17, no. 3, pp. 167–183, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. D. G. Wild, The Immunoassay Handbook: Theory and Applications of Ligand Binding, ELISA and Related Techniques, Elsevier, Amsterdam, Netherlands, 2013.
  27. M. E. Warkiani, B. L. Khoo, D. S.-W. Tan et al., “An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells,” Analyst, vol. 139, no. 13, pp. 3245–3255, 2014. View at Publisher · View at Google Scholar · View at Scopus